Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) — Capital Reinvestment Ratio
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Capital Reinvestment Ratio of 0.48x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥117.38 Million) in capital expenditures (CN¥56.87 Million). See 600436 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Capital Reinvestment Ratio (2001–2025)
This chart tracks Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 24 annual periods. Check Zhangzhou Pientzehuang Pharmaceutical Co total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Year-by-year Capital Reinvestment Ratio for Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2001 to 2025. For live market cap and broader valuation context, see Zhangzhou Pientzehuang Pharmaceutical Co stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.41x | CN¥77.03 Million | CN¥339.80 Million | ▲ +442.5% |
| 2024 | 0.81x | CN¥1.31 Billion | CN¥1.07 Billion | ▲ +1164.8% |
| 2023 | 0.06x | CN¥2.21 Billion | CN¥141.87 Million | ▲ +152.0% |
| 2022 | 0.03x | CN¥6.87 Billion | CN¥175.37 Million | ▼ -87.2% |
| 2021 | 0.20x | CN¥462.27 Million | CN¥92.17 Million | ▼ -30.2% |
| 2020 | 0.29x | CN¥1.47 Billion | CN¥419.01 Million | ▲ +135.6% |
| 2018 | 0.12x | CN¥612.31 Million | CN¥74.24 Million | ▲ +58.2% |
| 2017 | 0.08x | CN¥676.93 Million | CN¥51.87 Million | ▼ -66.8% |
| 2016 | 0.23x | CN¥394.54 Million | CN¥90.97 Million | ▼ -10.7% |
| 2015 | 0.26x | CN¥305.51 Million | CN¥78.86 Million | ▲ +164.0% |
| 2014 | 0.10x | CN¥264.50 Million | CN¥25.87 Million | ▼ -81.7% |
| 2013 | 0.53x | CN¥274.34 Million | CN¥146.54 Million | ▼ -44.1% |
| 2012 | 0.96x | CN¥162.40 Million | CN¥155.22 Million | ▲ +526.1% |
| 2011 | 0.15x | CN¥232.95 Million | CN¥35.56 Million | ▼ -19.4% |
| 2010 | 0.19x | CN¥205.41 Million | CN¥38.90 Million | ▼ -17.3% |
| 2009 | 0.23x | CN¥129.52 Million | CN¥29.67 Million | ▼ -95.1% |
| 2008 | 4.65x | CN¥12.57 Million | CN¥58.50 Million | ▲ +162.4% |
| 2007 | 1.77x | CN¥60.04 Million | CN¥106.47 Million | ▲ +932.2% |
| 2006 | 0.17x | CN¥50.70 Million | CN¥8.71 Million | ▼ -65.6% |
| 2005 | 0.50x | CN¥69.06 Million | CN¥34.54 Million | ▲ +358.9% |
| 2004 | 0.11x | CN¥98.67 Million | CN¥10.75 Million | ▼ -77.3% |
| 2003 | 0.48x | CN¥32.36 Million | CN¥15.56 Million | ▲ +419.2% |
| 2002 | 0.09x | CN¥105.45 Million | CN¥9.77 Million | ▼ -47.6% |
| 2001 | 0.18x | CN¥65.84 Million | CN¥11.64 Million | — |